The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)
NCATS announces the availability of funds for Administrative Supplements to enhance network capacity in the Clinical and Translational Sciences Awards (CTSA) program. These funds are intended to enhance network capacity through implementing, assessing, and/or disseminating discoveries in methods, approaches, education, and training in clinical and translational science. Funds will allow investigators from two or more different CTSA hubs to form collaborations within the CTSA network and/or with external partners to implement, assess, and/or disseminate discoveries across the network. These activities must be within the scope of the approved aims of the parent award and provide significant advances across the translational science spectrum.
Application Due Date(s): July 15, 2016; November 1, 2016; March 1, 2017; July 1, 2017; November 1, 2017; March 1, 2018; July 1, 2018; November 1, 2018; March 1, 2019
PA-16-328 Expiration Date March 2, 2019
This announcement is for supplements to existing projects. To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment. The proposed supplement must be to provide for an increase in costs due to unforeseen circumstances. All additional costs must be within the scope of the peer reviewed and approved project.
IMPORTANT: The research proposed by the NIH grantee in the supplement application must be within the original scope of the NIH-supported grant project.
This is a limited competition FOA. Applications must involve investigators from at least two active CTSA Institutions. For the purpose of this FOA, a CTSA institution is defined as the prime recipient of an active CTSA (U54/UL1) award made under Clinical and Translational Science Award (U54) (PAR-15-304); Clinical and Translational Science Award (U54) (RFA-TR-14-009); Institutional Clinical and Translational Science Award (U54) (RFA-TR-12-006); or Institutional Clinical and Translational Science Award (U54) (RFA-RM-10-020).
Application budgets are limited to no more than $300,000/year in direct costs excluding consortium/contractual F&A costs. The project and budget periods must be within the currently approved project period for the existing parent award. The requested project period may be up to two years.